Spots Global Cancer Trial Database for hydrocortisone
Every month we try and update this database with for hydrocortisone cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003) | NCT06136624 | Prostate Cancer... | Opevesostat Abiraterone ace... Enzalutamide Hydrocortisone Fludrocortisone... Prednisone Dexamethasone | - | Merck Sharp & Dohme LLC | |
| NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma | NCT01451515 | Lymphoblastic L... | Prednisone Vincristine Daunorubicin PEG-asparaginas... Erwinia asparag... Doxorubicin Cyclophosphamid... Cytarabine Thioguanine Clofarabine Methotrexate Mercaptopurine Dexamethasone Hydrocortisone Etoposide | - 21 Years | St. Jude Children's Research Hospital | |
| A Study in Adults With Untreated Acute Lymphoblastic Leukemia | NCT00136435 | Acute Lymphobla... | prednisone doxorubicin vincristine methotrexate asparaginase dexamethasone cranial radiati... leucovorin cytarabine hydrocortisone 6-mercaptopurin... e. coli L-aspar... | 18 Years - 50 Years | Dana-Farber Cancer Institute | |
| A Study of Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001) | NCT06136598 | Prostatic Neopl... Metastatic Cast... | Opevesostat Dexamethasone Fludrocortisone Hydrocortisone | 18 Years - | Merck Sharp & Dohme LLC | |
| Effect of Short Term Adrenal Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess | NCT01422707 | Hyperandrogenem... Obesity Polycystic Ovar... | Hydrocortisone | 7 Years - 18 Years | University of Virginia | |
| ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016 | NCT03286634 | Down Syndrome Acute Lymphobla... Childhood Cance... | Daunorubicin Prednisolone Vincristine Epirubicin E-coli L-aspara... 6-Mercaptopurin... Methotrexate Hydrocortisone Cytarabine Cyclophosphamid... | 0 Years - 20 Years | National Hospital Organization Nagoya Medical Center | |
| Venetoclax Basket Trial for High Risk Hematologic Malignancies | NCT05292664 | Myelodysplastic... Myelodysplastic... Myelodysplastic... Treatment-Relat... Therapy-Related... Acute Lymphobla... Acute Lymphobla... Lymphoblastic L... Lymphoblastic L... Acute Leukemia ... Acute Leukemia ... | Venetoclax Azacitidine Cytarabine Methotrexate Hydrocortisone Leucovorin Dexamethasone Vincristine Doxorubicin Dexrazoxane Calaspargase Pe... Erwinia asparag... | 1 Year - 40 Years | Dana-Farber Cancer Institute | |
| EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) | NCT01186328 | Lymphoblastic L... Lymphoblastic L... Leukemia, Lymph... Leukemia, Lymph... | EZN-3042 Cytarabine Doxorubicin Prednisone Vincristine PEG-asparaginas... Methotrexate Hydrocortisone | 1 Year - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL) | NCT03792256 | Leukemia, Lymph... Lymphoblastic L... T-cell Lymphoma T-cell Leukemia Recurrent Disea... Acute Leukemia | Palbociclib Cytarabine Methotrexate Hydrocortisone Doxorubicin Prednisolone Vincristine Pegaspargase Hydrocortisone Prednisone | 12 Months - 31 Years | Children's Oncology Group | |
| Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies | NCT05476770 | Hematologic Mal... AML ALL BPDCN MDS Lymphoblastic L... Lymphoma, B-Cel... Lymphoma, T-Cel... Hodgkin Lymphom... Mixed Phenotype... Acute Undiffere... | Tagraxofusp Fludarabine Cytarabine Dexamethasone Vincristine Azacitidine Methotrexate Cytarabine IT Hydrocortisone | 1 Year - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive | NCT00526305 | Acute Lymphobla... | Vincristine Daunorubicin Prednisone L-Asparaginase Mitoxantrone Cytosine Arabin... Hydrocortisone Mercaptopurine Cyclophosphamid... Dexamethasone | - 65 Years | PETHEMA Foundation | |
| Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer | NCT00673127 | Prostate Cancer | Ketoconazole, H... | 18 Years - | Dana-Farber Cancer Institute | |
| Treatment of Mature B-ALL and Burkitt Lymphoma (BL) in Adult Patients. BURKIMAB-14. | NCT05049473 | Mature B-Cell L... Burkitt Lymphom... Unclassifiable ... | Rituximab Methotrexate Dexamethasone Iphosphamid Vincristine Etoposide Cytarabine Cyclophosphamid... Doxorubicin Vindesine Cytarabine Methotrexate Hydrocortisone Prednisone | 18 Years - | PETHEMA Foundation | |
| Treatment of High Risk Adult Acute Lymphoblastic Leukemia | NCT00853008 | Acute Lymphobla... | Vincristine Daunorubicin Prednisone Mitoxantrone Cytosine Arabin... Dexamethasone Methotrexate (M... Cytarabine ASP Mercaptopurine Teniposide Hydrocortisone | 16 Years - | PETHEMA Foundation | |
| Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients | NCT05974410 | Glioblastoma Squamous Cell C... Hodgkin Lymphom... Non-hodgkin Lym... Breast Cancer Prostate Cancer Gastric Cancer Ovarian Cancer Acute Leukemia Pancreatic Canc... Spindle Cell Sa... Cancer Tumor, Solid Tumor, Brain | AVM0703 Hydrocortisone Proton pump inh... | - | AVM Biotechnology Inc | |
| Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies | NCT05476770 | Hematologic Mal... AML ALL BPDCN MDS Lymphoblastic L... Lymphoma, B-Cel... Lymphoma, T-Cel... Hodgkin Lymphom... Mixed Phenotype... Acute Undiffere... | Tagraxofusp Fludarabine Cytarabine Dexamethasone Vincristine Azacitidine Methotrexate Cytarabine IT Hydrocortisone | 1 Year - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia | NCT03913559 | Acute Lymphobla... | Inotuzumab ozog... Methotrexate Hydrocortisone Cytarabine Diphenhydramine Acetaminophen Methylprednisol... | - 21 Years | St. Jude Children's Research Hospital | |
| Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL) | NCT00131053 | Lymphoblastic L... | Methotrexate Prednisolone Dexamethasone Vincristine Pirarubicin Cyclophosphamid... L-asparaginase Cytarabine Hydrocortisone Mercaptopurine | 15 Years - 24 Years | Japan Adult Leukemia Study Group | |
| Effect of Perioperative Glucocorticoid Replacement on Prognosis of Surgical Patients With Sellar Lesions | NCT02190994 | Pituitary Neopl... Craniopharyngio... | Hydrocortisone Prednisone | 18 Years - | West China Hospital | |
| Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction | NCT01422733 | Hyperandrogenem... Obesity Polycystic Ovar... | Hydrocortisone dexamethasone Cosyntropin rhCG | 7 Years - 16 Years | University of Virginia | |
| A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005) | NCT06104449 | Prostatic Neopl... Metastatic Cast... | Opevesostat Dexamethasone Fludrocortisone... Hydrocortisone | 18 Years - | Merck Sharp & Dohme LLC | |
| ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016 | NCT03286634 | Down Syndrome Acute Lymphobla... Childhood Cance... | Daunorubicin Prednisolone Vincristine Epirubicin E-coli L-aspara... 6-Mercaptopurin... Methotrexate Hydrocortisone Cytarabine Cyclophosphamid... | 0 Years - 20 Years | National Hospital Organization Nagoya Medical Center | |
| Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies | NCT05476770 | Hematologic Mal... AML ALL BPDCN MDS Lymphoblastic L... Lymphoma, B-Cel... Lymphoma, T-Cel... Hodgkin Lymphom... Mixed Phenotype... Acute Undiffere... | Tagraxofusp Fludarabine Cytarabine Dexamethasone Vincristine Azacitidine Methotrexate Cytarabine IT Hydrocortisone | 1 Year - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| Ketoconazole and Dexamethasone in Prostate Cancer | NCT01036594 | Prostate Cancer | Ketoconazole Hydrocortisone Dexamethasone | 18 Years - | University of California, San Francisco | |
| Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents | NCT03020030 | Acute Lymphobla... | Pegaspargase Erwinia asparag... Cyclophosphamid... CYTARABINE DASATINIB DEXAMETHASONE Dexrazoxane Doxorubicin ETOPOSIDE HYDROCORTISONE LEUCOVORIN CALC... MERCAPTOPURINE METHOTREXATE NELARABINE Vincristine | 1 Year - 21 Years | Dana-Farber Cancer Institute | |
| Treatment of High Risk Adult Acute Lymphoblastic Leukemia | NCT00853008 | Acute Lymphobla... | Vincristine Daunorubicin Prednisone Mitoxantrone Cytosine Arabin... Dexamethasone Methotrexate (M... Cytarabine ASP Mercaptopurine Teniposide Hydrocortisone | 16 Years - | PETHEMA Foundation | |
| Pevonedistat With VXLD Chemotherapy for Adolescent/Young Adults With Relapsed/Refractory ALL or Lymphoblastic NHL | NCT03349281 | Refractory Acut... Relapsed Acute ... | Pevonedistat Vincristine Dexamethasone PEG-asparaginas... Doxorubicin Cytarabine Methotrexate Hydrocortisone | 16 Years - 39 Years | University of Miami | |
| Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior Chemotherapy | NCT00895310 | Prostate Cancer | Ketoconazole Hydrocortisone | 18 Years - | University of California, Davis | |
| Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer | NCT00953576 | Prostate Cancer | ketoconazole hydrocortisone dutasteride lapatinib | 18 Years - | Dana-Farber Cancer Institute | |
| Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia | NCT03913559 | Acute Lymphobla... | Inotuzumab ozog... Methotrexate Hydrocortisone Cytarabine Diphenhydramine Acetaminophen Methylprednisol... | - 21 Years | St. Jude Children's Research Hospital | |
| 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer | NCT00859781 | Prostate Cancer | 177Lu-J591 Ketoconazole Hydrocortisone 111In-J591 | 18 Years - | Weill Medical College of Cornell University | |
| Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG | NCT00899847 | Transplantation... Transplantation... Multiple Myelom... Blood and Marro... | Autologous peri... Allogeneic peri... Filgrastim Cyclophosphamid... Melphalan Cyclosporine Total lymphoid ... Rabbit anti-thy... Mycophenolate M... Solumedrol Diphenhydramine Acetaminophen Hydrocortisone | 18 Years - 75 Years | Stanford University | |
| Allogeneic Transplantation From Related Haploidentical Donors | NCT00185692 | Blood Cancer Leukemia Graft Versus Ho... Malignancy CLL NHL Hodgkin's Disea... MDS | non-myeloablati... Anti-Thymocyte ... Cyclosporine Mycophenolate M... G-CSF Solumedrol Acetaminophen Diphenydramine Hydrocortisone | 12 Months - | Stanford University | |
| Effect of Perioperative Glucocorticoid Replacement on Prognosis of Surgical Patients With Sellar Lesions | NCT02190994 | Pituitary Neopl... Craniopharyngio... | Hydrocortisone Prednisone | 18 Years - | West China Hospital | |
| Dual RElease Hydrocortisone Versus conventionAl Glucocorticoid replaceMent Therapy in Hypocortisolism (DREAM) | NCT02277587 | Primary Adrenal... Secondary Adren... | Plenadren Conventional gl... | 18 Years - 80 Years | University of Roma La Sapienza | |
| Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD | NCT00186628 | Leukemia, Mast-... Mantle-cell Lym... | Total lymphoid ... Rituximab Anti-thymoglobu... Cyclosporine Mycophenylate m... Filgrastim Granisetron Solumedrol Acetaminophen Diphenhydramine Hydrocortisone | 18 Years - 76 Years | Stanford University | |
| Trilostane for Androgen-Independent Prostate Cancer | NCT00181597 | Prostate Cancer Prostate Adenoc... | Trilostane Hydrocortisone | 18 Years - | Sanofi | |
| Dual RElease Hydrocortisone Versus conventionAl Glucocorticoid replaceMent Therapy in Hypocortisolism (DREAM) | NCT02277587 | Primary Adrenal... Secondary Adren... | Plenadren Conventional gl... | 18 Years - 80 Years | University of Roma La Sapienza | |
| Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma | NCT02043587 | Acute Lymphocyt... Adult Lymphobla... | DNR VCR PEG-asp CTX Prednisone Liposomal AraC MTX LCV AraC Etoposide Dasatinib Rituximab Hydrocortisone | 18 Years - 60 Years | University of California, San Diego | |
| A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma | NCT01614197 | Lymphoblastic L... Lymphoblastic L... Peripheral T-ce... | Temsirolimus Etoposide Cyclophosphamid... Methotrexate Hydrocortisone Cytarabine | 1 Year - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| Hydrocortisone Treatment for Symmetric Lipomatosis Associated With Neuropathy (SLN): an N-of-1 Study Hydrocortisone Treatment for Symmetric Lipomatosis Associated With Neuropathy (SLN): an N-of-1 Study | NCT04821583 | Symmetric Lipom... | Hydrocortisone Placebo | 31 Years - | Erasmus Medical Center | |
| HYPAR Trial - Hydrocortisone vs. Pasireotide in Reducing Pancreatic Surgery Complications | NCT02775227 | Pancreatic Fist... Pancreatic Neop... | Hydrocortisone Pasireotide | 18 Years - | Helsinki University Central Hospital | |
| A Study in Adults With Untreated Acute Lymphoblastic Leukemia | NCT00136435 | Acute Lymphobla... | prednisone doxorubicin vincristine methotrexate asparaginase dexamethasone cranial radiati... leucovorin cytarabine hydrocortisone 6-mercaptopurin... e. coli L-aspar... | 18 Years - 50 Years | Dana-Farber Cancer Institute | |
| Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia | NCT00133991 | Leukemia Lymphoma | Filgrastim Rituximab Cyclophosphamid... Cytarabine Methotrexate Prednisone Hydrocortisone Vincristine Leucovorin | 30 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents | NCT03020030 | Acute Lymphobla... | Pegaspargase Erwinia asparag... Cyclophosphamid... CYTARABINE DASATINIB DEXAMETHASONE Dexrazoxane Doxorubicin ETOPOSIDE HYDROCORTISONE LEUCOVORIN CALC... MERCAPTOPURINE METHOTREXATE NELARABINE Vincristine | 1 Year - 21 Years | Dana-Farber Cancer Institute | |
| Pevonedistat With VXLD Chemotherapy for Adolescent/Young Adults With Relapsed/Refractory ALL or Lymphoblastic NHL | NCT03349281 | Refractory Acut... Relapsed Acute ... | Pevonedistat Vincristine Dexamethasone PEG-asparaginas... Doxorubicin Cytarabine Methotrexate Hydrocortisone | 16 Years - 39 Years | University of Miami | |
| A Study of Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001) | NCT06136598 | Prostatic Neopl... Metastatic Cast... | Opevesostat Dexamethasone Fludrocortisone Hydrocortisone | 18 Years - | Merck Sharp & Dohme LLC | |
| Peri-Operative Steroid Management in Patients | NCT02084134 | Pituitary Adeno... Pituitary Disea... | hydrocortisone dexamethasone | 18 Years - | Washington University School of Medicine | |
| Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction | NCT01422733 | Hyperandrogenem... Obesity Polycystic Ovar... | Hydrocortisone dexamethasone Cosyntropin rhCG | 7 Years - 16 Years | University of Virginia | |
| Hydrocortisone Use During Peri-operation for Pituitary Adenomas | NCT04621565 | Pituitary Adeno... Adrenal Insuffi... Surgery | Normal saline Hydrocortisone | 18 Years - 70 Years | Peking Union Medical College Hospital | |
| Pevonedistat With VXLD Chemotherapy for Adolescent/Young Adults With Relapsed/Refractory ALL or Lymphoblastic NHL | NCT03349281 | Refractory Acut... Relapsed Acute ... | Pevonedistat Vincristine Dexamethasone PEG-asparaginas... Doxorubicin Cytarabine Methotrexate Hydrocortisone | 16 Years - 39 Years | University of Miami | |
| EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) | NCT01186328 | Lymphoblastic L... Lymphoblastic L... Leukemia, Lymph... Leukemia, Lymph... | EZN-3042 Cytarabine Doxorubicin Prednisone Vincristine PEG-asparaginas... Methotrexate Hydrocortisone | 1 Year - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| Venetoclax Basket Trial for High Risk Hematologic Malignancies | NCT05292664 | Myelodysplastic... Myelodysplastic... Myelodysplastic... Treatment-Relat... Therapy-Related... Acute Lymphobla... Acute Lymphobla... Lymphoblastic L... Lymphoblastic L... Acute Leukemia ... Acute Leukemia ... | Venetoclax Azacitidine Cytarabine Methotrexate Hydrocortisone Leucovorin Dexamethasone Vincristine Doxorubicin Dexrazoxane Calaspargase Pe... Erwinia asparag... | 1 Year - 40 Years | Dana-Farber Cancer Institute | |
| A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005) | NCT06104449 | Prostatic Neopl... Metastatic Cast... | Opevesostat Dexamethasone Fludrocortisone... Hydrocortisone | 18 Years - | Merck Sharp & Dohme LLC | |
| Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT | NCT00482053 | Lymphoma, B-cel... Lymphoma, Non-H... Diffuse Large B... Malignant Lymph... | Autologous hema... Allogeneic hema... Total lymphoid ... Rituximab Carmustine Etoposide Filgrastim Anti-thymocyte ... Cyclosporine Mycophenolate m... Cyclophosphamid... Acetaminophen Diphenhydramine Hydrocortisone Methylprednisol... | 18 Years - 70 Years | Stanford University | |
| Ketoconazole and Dexamethasone in Prostate Cancer | NCT01036594 | Prostate Cancer | Ketoconazole Hydrocortisone Dexamethasone | 18 Years - | University of California, San Francisco | |
| Hydrocortisone Treatment for Symmetric Lipomatosis Associated With Neuropathy (SLN): an N-of-1 Study Hydrocortisone Treatment for Symmetric Lipomatosis Associated With Neuropathy (SLN): an N-of-1 Study | NCT04821583 | Symmetric Lipom... | Hydrocortisone Placebo | 31 Years - | Erasmus Medical Center | |
| Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003) | NCT06136624 | Prostate Cancer... | Opevesostat Abiraterone ace... Enzalutamide Hydrocortisone Fludrocortisone... Prednisone Dexamethasone | - | Merck Sharp & Dohme LLC |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
